Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Pigmentation Disorder Treatment Market: By Disease Indication: Melasma, Vitiligo, Albinism, Post-Inflammatory Hyperpigmentation; By Treatment Type; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2016-2026); Value Chain Analysis; Competitive Landscape; Industry Events and Developments
Global Pigmentation Disorder Treatment Market Outlook
The global pigmentation disorder treatment market is expected to grow at a CAGR of about 7.4% in the forecast period of 2021-2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America Leading the Pigmentation Disorder Treatment Industry
North America leads the global market for treatment of pigmentation disorders due to increasing pigmentation disorders. Presence of well-established healthcare system and major market players offering appropriate treatment options for post-inflammatory hyperpigmentation patients are propelling the growth of the market in the region. North America has had the largest share in the global market for treatment of pigmentation disorders and is expected to maintain the same trend over the forecast period due to the increasing ageing population.
Pigmentation Disorder Treatment: Industry Definition and Segmentation
Pigmentation disorders include a wide variety of different conditions that are typically characterised by altered melanocyte density, melanin concentration, or both and result in altered skin pigmentation. Some of these conditions are very common, while others are rare. Pigmentation conditions are known as hypopigmentation or hyperpigmentation. In hypopigmentation, the pigment is diminished, and in depigmentation, the pigment is totally lost, leaving the skin white.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The disease indication can be divided as follows:
- Melasma
- Vitiligo
- Albinism
- Post-Inflammatory Hyperpigmentation
Based on treatment type, the market can be divided as follows:
- Pharmacological Treatment
- Topical drugs
- Hydroquinone
- Azelaic Acid
- L-Ascorbic Acid
- Others
- Cosmetic Treatment
- Chemical Peel
- Laser Therapy
- Dermabrasion
- Skin Grafting
- Others
On the basis of distribution channel, the industry can be categorised as follows:
- Dermatology Clinics
- Aesthetic Clinics
- Drugstores and Cosmetic Stores
- E-Commerce
- Others
The regional markets for pigmentation disorder treatment can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Changing Lifestyles Bolstering the Market Growth
Upgraded lifestyle combined with increased demand for skin lightening is projected to be the primary driver of the pigmentation disorder treatment industry. Growing ageing population, rising occurrence rates of skin disorders, increasing number of smokers, global warming and increasing disposable income are some of those factors that drive the pigmentation disorders treatment market. In addition, advances in tissue engineering coupled with the adoption of novel techniques and skin care products are expected to further increase the demand during the forecast period.
Key Industry Players in the Global Pigmentation Disorder Treatment Market
The report gives a detailed analysis of the following key players in the global pigmentation disorder treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- SkinCeuticals International
- Pierre Fabre Laboratories
- Obagi Medical Products Inc.
- Others
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2016-2020 |
| Forecast Period | 2021-2026 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Disease Indication, Treatment Type, Distribution Channel, Region |
| Breakup by Disease Indication | Melasma, Vitiligo, Albinism, Post-Inflammatory Hyperpigmentation |
| Breakup by Treatment Type | Pharmacological Treatment, Cosmetic Treatment |
| Breakup by Distribution Channel | Dermatology Clinics, Aesthetic Clinics, Drugstores and Cosmetic Stores, E-Commerce, Others |
| Breakup by Region | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | SkinCeuticals International, Pierre Fabre Laboratories, Obagi Medical Products Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Pigmentation Disorder Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Pigmentation Disorder Treatment Historical Market (2016-2020)
8.3 Global Pigmentation Disorder Treatment Market Forecast (2021-2026)
8.4 Global Pigmentation Disorder Treatment Market by Disease Indication
8.4.1 Melasma
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2016-2020)
8.4.1.3 Forecast Trend (2021-2026)
8.4.2 Vitiligo
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2016-2020)
8.4.2.3 Forecast Trend (2021-2026)
8.4.3 Albinism
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2016-2020)
8.4.3.3 Forecast Trend (2021-2026)
8.4.4 Post-Inflammatory Hyperpigmentation
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2016-2020)
8.4.4.3 Forecast Trend (2021-2026)
8.5 Global Pigmentation Disorder Treatment Market by Treatment Type
8.5.1 Pharmacological Treatment
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2016-2020)
8.5.1.3 Forecast Trend (2021-2026)
8.5.1.4 Market by Type
8.5.1.4.1 Topical drugs
8.5.1.4.2 Hydroquinone
8.5.1.4.3 Azelaic Acid
8.5.1.4.4 L-Ascorbic Acid
8.5.1.4.5 Others
8.5.2 Cosmetic Treatment
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2016-2020)
8.5.2.3 Forecast Trend (2021-2026)
8.5.2.4 Market by Type
8.5.2.4.1 Chemical Peel
8.5.2.4.2 Laser Therapy
8.5.2.4.3 Dermabrasion
8.5.2.4.4 Skin Grafting
8.5.2.4.5 Others
8.6 Global Pigmentation Disorder Treatment Market by Distribution Channel
8.6.1 Dermatology Clinics
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2016-2020)
8.6.1.3 Forecast Trend (2021-2026)
8.6.2 Aesthetic Clinics
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2016-2020)
8.6.2.3 Forecast Trend (2021-2026)
8.6.3 Drugstores and Cosmetic Stores
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2016-2020)
8.6.3.3 Forecast Trend (2021-2026)
8.6.4 E-Commerce
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2016-2020)
8.6.4.3 Forecast Trend (2021-2026)
8.6.5 Others
8.7 Global Pigmentation Disorder Treatment Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Key Players’ Market Share
12.3 Company Profiles
12.3.1 SkinCeuticals International
12.3.1.1 Company Overview
12.3.1.2 Product Portfolio
12.3.1.3 Demographic Reach and Achievements
12.3.1.4 Certifications
12.3.2 Pierre Fabre Laboratories
12.3.2.1 Company Overview
12.3.2.2 Product Portfolio
12.3.2.3 Demographic Reach and Achievements
12.3.2.4 Certifications
12.3.3 Obagi Medical Products Inc.
12.3.3.1 Company Overview
12.3.3.2 Product Portfolio
12.3.3.3 Demographic Reach and Achievements
12.3.3.4 Certifications
12.3.4 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Pigmentation Disorder Treatment Market: Key Industry Highlights, 2015 and 2025
2. Global Pigmentation Disorder Treatment Historical Market: Breakup by Disease Indication (USD Billion), 2016-2020
3. Global Pigmentation Disorder Treatment Market Forecast: Breakup by Disease Indication (USD Billion), 2021-2026
4. Global Pigmentation Disorder Treatment Historical Market: Breakup by Treatment Type (USD Billion), 2016-2020
5. Global Pigmentation Disorder Treatment Market Forecast: Breakup by Treatment Type (USD Billion), 2021-2026
6. Global Pigmentation Disorder Treatment Historical Market: Breakup by Distribution Channel (USD Billion), 2016-2020
7. Global Pigmentation Disorder Treatment Market Forecast: Breakup by Distribution Channel (USD Billion), 2021-2026
8. Global Pigmentation Disorder Treatment Historical Market: Breakup by Region (USD Billion), 2016-2020
9. Global Pigmentation Disorder Treatment Market Forecast: Breakup by Region (USD Billion), 2021-2026
10. North America Pigmentation Disorder Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
11. North America Pigmentation Disorder Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
12. Europe Pigmentation Disorder Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
13. Europe Pigmentation Disorder Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
14. Asia Pacific Pigmentation Disorder Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
15. Asia Pacific Pigmentation Disorder Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
16. Latin America Pigmentation Disorder Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
17. Latin America Pigmentation Disorder Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
18. Middle East and Africa Pigmentation Disorder Treatment Historical Market: Breakup by Country (USD Billion), 2016-2020
19. Middle East and Africa Pigmentation Disorder Treatment Market Forecast: Breakup by Country (USD Billion), 2021-2026
20. Global Pigmentation Disorder Treatment Market Structure
Key Questions Answered in the Report
The global pigmentation disorder treatment market is projected to grow at a CAGR of nearly 7.4% in the forecast period of 2021-2026.
The growth of the market is being driven by factors like rising ageing population, increased urbanisation, changing lifestyles, technical advancements, and the rising disposable incomes.
Advances in tissue engineering and the adoption of novel techniques is a key industry trend.
What are the major regional markets of pigmentation disorder treatment, according to the EMR report?
North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the leading regions in the market, with North America accounting for the largest market share.
The disease indications include melasma, vitiligo, albinism, and post-inflammatory hyperpigmentation.
The treatment types can be divided into pharmacological treatment and cosmetic treatment.
The distribution channels for the industry include dermatology clinics, aesthetic clinics, drugstores and cosmetic stores, and e-commerce, among others.
The leading players in the market are SkinCeuticals International, Pierre Fabre Laboratories, and Obagi Medical Products Inc., among others.
Analyst Review
The global pigmentation disorder treatment market is being driven by the rising ageing population. Aided by the rapid advances in tissue engineering and the adoption of novel techniques, the industry is expected to witness a healthy growth in the forecast period of 2021-2026, growing at a CAGR of 7.4%.
EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on its disease indications, the global market for pigmentation disorder treatment can be segmented into melasma, vitiligo, albinism, and post-inflammatory hyperpigmentation. On the basis of treatment types, the global industry can be divided into pharmacological treatment and cosmetic treatment. The distribution channels include dermatology clinics, aesthetic clinics, drugstores and cosmetic stores, and e-commerce, among others. The major regional markets for pigmentation disorder treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the market. The key players in the above industry include SkinCeuticals International, Pierre Fabre Laboratories, and Obagi Medical Products Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global therapeutic beds market attained a value of USD 3.37 billion in 2020. The market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 5.38% to reach USD 4.61 billion...
The global allergy treatment market attained a value of 17.9 billion in 2020, driven by the growing popularity of immunotherapy. Aided by the growing R&D activities towards the development of anti-all...
The global cancer immunotherapy market stood at a value of around USD 86,607 million in 2020. The market is further expected to grow at a CAGR of 9.7% in the forecast period of 2021-2026 to attain a v...
The global sickle cell disease treatment market stood at a value of around USD 3.4 billion in 2020. The market is further expected to grow at a CAGR of 16.9% in the forecast period of 2021-2026 to att...
The global dry eye disease treatment market attained a value of nearly USD 5 billion in 2020, driven by the rising prevalence of eye complications among the growing geriatric population. Aided by the ...
NEWSLETTER